Nancy Loos

In June 2019, I joined the group of Alfred Schinkel as a PhD student. My project focuses on the therapeutic relevance of pharmacological CYP3A inhibition in taxane chemotherapy, which I study using mouse models and in vitro studies. Furthermore, I am following courses to qualify as a clinical pharmacologist.